Vasopressin: Difference between revisions

(Created page with "==General== *Type: Vasopressors *Dosage Forms: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug Ratings in Pregnancy|Pregnanc...")
 
No edit summary
Line 5: Line 5:


==Adult Dosing==
==Adult Dosing==
===Dosing===
*0.04 units/min
===Rate of Titration===
*Fixed dose (do not titrate)


==Pediatric Dosing==
==Pediatric Dosing==
Line 22: Line 26:


==Adverse Reactions==
==Adverse Reactions==
===Serious===
*Bradycardia
 
*Limb ischemia
===Common===
*Myocardial ischemia
*Splanchnic ischemia


==Pharmacology==
==Pharmacology==
Line 31: Line 36:
*Excretion:  
*Excretion:  
*Mechanism of Action:
*Mechanism of Action:
===Primary Receptor===
*V1
===Relative Effects===
*↑SVR
*↓HR
==Notes==
*Adverse effects are dose-dependent
*Acts on V1 receptors leading to ↑vasoconstriction and
↑sensitivity to catecholamines in pts with shock
===Indication===
*Adjunct for septic shock


==See Also==
==See Also==

Revision as of 14:27, 20 December 2014

General

Adult Dosing

Dosing

  • 0.04 units/min

Rate of Titration

  • Fixed dose (do not titrate)

Pediatric Dosing

Special Populations

  • Pregnancy Rating:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Bradycardia
  • Limb ischemia
  • Myocardial ischemia
  • Splanchnic ischemia

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

Primary Receptor

  • V1

Relative Effects

  • ↑SVR
  • ↓HR

Notes

  • Adverse effects are dose-dependent
  • Acts on V1 receptors leading to ↑vasoconstriction and

↑sensitivity to catecholamines in pts with shock

Indication

  • Adjunct for septic shock

See Also

Sources